Streetbeat News

Earnings

NKE

Goldman Sachs analyst Brooke Roach maintains a Buy rating on Nike (NYSE:NKE) with a $105 price target. The focus is on Nike's Q1 results, especially trends in China vs. North America. Investors are cautious due to mixed signals from China and franchise management uncertainties. A 10.5% YoY revenue decline and $0.51 EPS are expected for the quarter.

Portfolio Pulse from Nabaparna Bhattacharya

September 25, 2024 | 7:08 pm

PYCR

Paycor HCM (NASDAQ:PYCR) has been analyzed by 9 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target is $17.67, a 25.35% decline from the previous target. Analysts have adjusted their ratings and price targets, reflecting changing market dynamics. Paycor HCM has shown a 17.68% revenue growth but struggles with profitability, as indicated by its net margin, ROE, and ROA being below industry averages.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 7:00 pm

SFIX

Stitch Fix reported a Q4 2024 adjusted EPS of $(0.30), missing the $(0.19) estimate, but sales of $319.6M beat the $318.5M estimate. EPS decreased by 25% from last year, while sales dropped by 12.38%.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 6:51 pm

JBL

Jabil Inc. (NYSE:JBL) is set to release its Q4 earnings on Sept. 26, with expectations of lower earnings and revenue compared to last year. Analysts have revised their forecasts, maintaining mostly positive ratings but lowering price targets. Jabil recently expanded its silicon photonics capabilities.

Portfolio Pulse from Avi Kapoor

September 25, 2024 | 6:49 pm

CAPR

CERO

OCTO

SFIX

VTNR

U.S. stocks mostly declined with the Dow Jones falling over 200 points. CERo Therapeutics shares rose 13% after securing financing and requesting an FDA meeting. Capricor Therapeutics and Eightco Holdings also saw significant gains. Vertex Energy filed for bankruptcy, causing a 56% drop in its stock.

Portfolio Pulse from Avi Kapoor

September 25, 2024 | 6:49 pm

GPN

Global Payments Inc. (NYSE:GPN) shares fell after the company forecasted FY25 EPS growth below Wall Street estimates. Analysts downgraded the stock and lowered price targets due to the company's lower-than-expected growth outlook.

Portfolio Pulse from Lekha Gupta

September 25, 2024 | 6:46 pm

AER

FCNCA

GOOGL

Chris Ballard from Check Capital Management shares his top stock picks post-earnings: Alphabet, First Citizens BancShares, and AerCap. Alphabet shows strong growth in search and YouTube ads, First Citizens excels with low-risk banking, and AerCap benefits from strategic asset sales and buybacks.

Portfolio Pulse from Surbhi Jain

September 25, 2024 | 6:02 pm

GOOGL

Analysts have varied opinions on Alphabet (NASDAQ:GOOGL), with ratings ranging from bullish to bearish. The average 12-month price target is $203.09, slightly up from $201.48. Alphabet's financials show strong revenue growth and efficient cost management, with a high net margin and return on equity.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 6:01 pm

DHI

KBH

D.R. Horton shares are experiencing a decline, potentially in response to KB Home's report of flat orders, which has negatively impacted KB Home's stock.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 5:33 pm

AMGN

LLY

SNY

Amgen's Phase 3 trial data for rocatinlimab in atopic dermatitis shows commercial potential despite competition. Goldman Sachs maintains a Buy rating with a $370 price target, noting the drug's safety profile and market potential. Amgen's stock is down 4.67% following the update.

Portfolio Pulse from Vandana Singh

September 25, 2024 | 5:30 pm